| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund IDCW Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.21 |
| Equity |
100.06 |
| Trep |
0.15 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
41.03% |
| Top 10 Holdings |
60.76% |
| Top 25 Holdings |
93.43% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
62.27 |
| Healthcare |
37.79 |
| Cash |
-0.06 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.61 |
| PE Ratio |
42.44 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
15.07 |
| Lupin Limited |
8.52 |
| Fortis Health Care Ltd |
6.63 |
| Aurobindo Pharma Limited |
5.79 |
| Mankind Pharma Limited |
5.02 |
| Alkem Laboratories Limited |
4.88 |
| Laurus Labs Limited |
4.30 |
| Glenmark Pharmaceuticals Limited |
3.95 |
| IPCA Laboratories Limited |
3.57 |
| Krishna Inst of Medical Sciences Ltd. |
3.03 |
| Abbott India Limited |
2.86 |
| Biocon Limited |
2.73 |
| Glaxosmithkline Pharma Ltd |
2.46 |
| Cohance Lifesciences Limited |
2.40 |
| Piramal Pharma Limited |
2.29 |
| Gland Pharma Limited |
2.28 |
| Aster DM Healthcare Limited |
2.27 |
| Syngene International Limited |
2.20 |
| J B Chemicals and Pharma Ltd |
2.17 |
| Narayana Hrudalaya Ltd |
2.13 |
| Ajanta Pharma Limited |
1.90 |
| Dr Lal Path Labs Ltd |
1.87 |
| Neuland Laboratories Limited |
1.78 |
| EQ- GLOBAL HEALTH LTD. |
1.78 |
| Poly Medicure Limited |
1.55 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
